WisdomTree BioRevolution Fund Rating $14.54 -0.32 (-2.16%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.76Holdings in WDNA have an aggregate rating of Moderate Buy based on 713 analyst ratings issued in the past year covering 46 companies (70.8% of the portfolio).WDNA Aggregate Price Target$14.53High Prediction$14.53Average Prediction$14.53Low Prediction$14.53Holdings in WDNA have an aggregate price target of $14.53 and a range of $14.53 to $14.53 covering 46 companies (70.8% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy35 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.31%NTRANatera$162.31-3.5%2.5772 of 5 stars3.00$170.94 5.3%16Positive News4.06%TWSTTwist Bioscience$41.31-8.4%4.5944 of 5 stars2.70$54.40 31.7%10Positive News3.03%BPMCBlueprint Medicines$92.25-2.2%3.0079 of 5 stars2.65$123.83 34.2%20Earnings ReportAnalyst Upgrade2.82%VCELVericel$52.00-4.3%2.939 of 5 stars3.00$63.14 21.4%7Positive News2.69%VCYTVeracyte$39.18-4.6%2.9221 of 5 stars2.67$42.00 7.2%9Analyst DowngradeNews Coverage2.32%LLYEli Lilly and Company$874.12+0.1%4.8421 of 5 stars2.85$1,000.28 14.4%20Positive News2.15%BBIOBridgeBio Pharma$36.85+0.1%4.8189 of 5 stars2.92$51.67 40.2%13Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap Up1.84%AGIOAgios Pharmaceuticals$35.22+4.3%4.3287 of 5 stars2.50$56.33 60.0%8Earnings ReportShort Interest ↓1.76%UTHRUnited Therapeutics$361.10-1.7%4.3616 of 5 stars2.67$388.25 7.5%12Insider TradePositive News1.74%GERNGeron$2.58-2.1%3.0097 of 5 stars3.08$6.91 168.3%12Analyst ForecastAnalyst RevisionNews Coverage1.68%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4399 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade1.62%VRTXVertex Pharmaceuticals$484.24+0.8%4.0991 of 5 stars2.65$506.70 4.6%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News1.48%GILDGilead Sciences$109.95-0.1%4.7784 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News1.47%SRPTSarepta Therapeutics$106.28-2.0%4.4955 of 5 stars2.87$176.77 66.3%23Upcoming EarningsPositive News1.38%LHLaboratory Co. of America$249.86+0.3%4.767 of 5 stars2.88$265.31 6.2%16Positive News1.38%BMYBristol-Myers Squibb$55.85+0.1%4.5826 of 5 stars2.30$57.86 3.6%20Analyst RevisionPositive News1.37%RAREUltragenyx Pharmaceutical$42.59-4.2%4.6132 of 5 stars2.93$93.50 119.5%14Analyst Forecast1.37%AMGNAmgen$303.01+1.7%4.4545 of 5 stars2.46$314.09 3.7%24Insider TradePositive News1.37%CTVACorteva$62.75-1.7%4.4731 of 5 stars2.67$67.73 7.9%18News CoveragePositive News1.34%DDDuPont de Nemours$81.67-1.4%4.7405 of 5 stars2.83$98.75 20.9%12Dividend IncreaseAnalyst UpgradePositive News1.33%TMOThermo Fisher Scientific$532.55-1.0%4.7267 of 5 stars2.82$656.86 23.3%22Dividend IncreaseAnalyst RevisionPositive News1.30%FOLDAmicus Therapeutics$9.19+1.3%4.173 of 5 stars2.78$16.75 82.3%9Analyst DowngradeNews Coverage1.28%BNTXBioNTech$120.01+1.8%2.4313 of 5 stars2.88$142.72 18.9%17Positive NewsHigh Trading Volume1.28%DHRDanaher$209.86+0.9%4.992 of 5 stars2.71$278.00 32.5%21Dividend IncreaseAnalyst RevisionPositive News1.24%TSNTyson Foods$60.43+2.2%4.5338 of 5 stars2.09$61.10 1.1%11Positive News1.23%ZTSZoetis$160.39+1.9%4.8684 of 5 stars3.08$215.40 34.3%12Positive News1.23%RGENRepligen$158.99-2.3%4.424 of 5 stars2.62$181.00 13.8%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.21%BEAMBeam Therapeutics$30.43-8.2%3.125 of 5 stars3.00$47.67 56.6%12Gap Up1.21%IOVAIovance Biotherapeutics$5.78+3.0%4.0186 of 5 stars2.86$21.07 264.6%71.19%JNJJohnson & Johnson$162.35+1.7%4.5371 of 5 stars2.56$170.67 5.1%18Ex-DividendAnalyst ForecastOptions VolumePositive News1.19%QGENQiagen$39.52+2.5%4.4256 of 5 stars2.30$47.71 20.7%10Analyst Downgrade1.18%STOKStoke Therapeutics$8.33-4.7%3.684 of 5 stars3.00$23.00 176.1%10Analyst ForecastAnalyst RevisionNews Coverage1.17%NEONeoGenomics$11.10-6.4%2.9621 of 5 stars2.80$19.80 78.4%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.15%AZNAstraZeneca$74.20-0.5%2.6875 of 5 stars3.10$89.75 21.0%10Options Volume1.14%DARDarling Ingredients$39.18-1.0%4.2498 of 5 stars2.89$53.22 35.8%9News CoveragePositive News1.11%MRKMerck & Co., Inc.$89.40+2.0%5 of 5 stars2.58$116.39 30.2%24Analyst DowngradeOptions Volume1.06%TECHBio-Techne$64.92-0.9%4.9189 of 5 stars2.50$84.29 29.8%8Analyst DowngradeInsider TradeNews Coverage1.04%ILMNIllumina$94.20-3.1%4.7705 of 5 stars2.62$159.45 69.3%211.04%EXASExact Sciences$49.26-0.5%4.6827 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.03%CRSPCRISPR Therapeutics$47.91-5.0%3.157 of 5 stars2.50$74.40 55.3%22Analyst ForecastInsider TradeOptions VolumeAnalyst Revision1.02%IONSIonis Pharmaceuticals$32.33-1.1%4.4165 of 5 stars2.70$60.00 85.6%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.02%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7594 of 5 stars2.76$973.13 39.0%25Dividend Announcement1.01%BIOBio-Rad Laboratories$279.48-2.2%4.7938 of 5 stars2.60$395.20 41.4%51.01%TEMTempus AI$68.09-11.2%1.3861 of 5 stars2.67$58.55 -14.0%12Insider TradeGap Up1.00%SDGRSchrödinger$22.64-5.7%1.9377 of 5 stars2.80$32.11 41.8%10Upcoming Earnings0.94%ARGXargenx$644.48-0.5%2.4974 of 5 stars2.86$658.39 2.2%22News CoveragePositive News This page (BATS:WDNA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
